Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications
T Xiao, J Lee, TD Gauntner, M Velegraki… - Nature Reviews …, 2024 - nature.com
Sex differences are present across multiple non-reproductive organ cancers, with male
individuals generally experiencing higher incidence of cancer with poorer outcomes …
individuals generally experiencing higher incidence of cancer with poorer outcomes …
COPD and Immune Checkpoint Inhibitors for Cancer: A Literature Review
TW Lycan Jr, DL Norton, JA Ohar - International Journal of Chronic …, 2024 - Taylor & Francis
Purpose Immune checkpoint inhibitors are a standard treatment option for many patients
with cancer and are most frequently used to treat lung cancer. Chronic obstructive …
with cancer and are most frequently used to treat lung cancer. Chronic obstructive …
[PDF][PDF] Oncologia di Genere: studio sperimentale osservazionale sulle differenze di genere delle tossicità da immunoterapia nei pazienti oncologici.
G MARTINUZZI - 2022 - tesi.univpm.it
Abstract La Medicina di Genere viene definita dall'Organizzazione Mondiale della Sanità
(OMS) come lo studio dell'influenza delle differenze biologiche (definite dal sesso) e socio …
(OMS) come lo studio dell'influenza delle differenze biologiche (definite dal sesso) e socio …